DE69608891D1 - Tetraline mit einem phenylsubstituenten am aromatischen ring und ihre verwendung in der behandlung von epilepsie, schlaganfall und gehirn- oder rückenmarkstrauma - Google Patents
Tetraline mit einem phenylsubstituenten am aromatischen ring und ihre verwendung in der behandlung von epilepsie, schlaganfall und gehirn- oder rückenmarkstraumaInfo
- Publication number
- DE69608891D1 DE69608891D1 DE69608891T DE69608891T DE69608891D1 DE 69608891 D1 DE69608891 D1 DE 69608891D1 DE 69608891 T DE69608891 T DE 69608891T DE 69608891 T DE69608891 T DE 69608891T DE 69608891 D1 DE69608891 D1 DE 69608891D1
- Authority
- DE
- Germany
- Prior art keywords
- tetraline
- epilepsy
- trauma
- brain
- stroke
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9509156.7A GB9509156D0 (en) | 1995-05-05 | 1995-05-05 | Organic compounds |
PCT/EP1996/001841 WO1996034849A1 (en) | 1995-05-05 | 1996-05-03 | Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69608891D1 true DE69608891D1 (de) | 2000-07-20 |
DE69608891T2 DE69608891T2 (de) | 2000-11-16 |
Family
ID=10774032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69608891T Expired - Lifetime DE69608891T2 (de) | 1995-05-05 | 1996-05-03 | Tetraline mit einem phenylsubstituenten am aromatischen ring und ihre verwendung in der behandlung von epilepsie, schlaganfall und gehirn- oder rückenmarkstrauma |
Country Status (33)
Country | Link |
---|---|
US (1) | US6169116B1 (de) |
EP (1) | EP0823892B1 (de) |
JP (1) | JP3194965B2 (de) |
KR (1) | KR100435009B1 (de) |
CN (1) | CN1122019C (de) |
AR (1) | AR004484A1 (de) |
AT (1) | ATE193884T1 (de) |
AU (1) | AU706392B2 (de) |
BR (1) | BR9608169A (de) |
CA (1) | CA2217855C (de) |
CO (1) | CO4440486A1 (de) |
CZ (1) | CZ292022B6 (de) |
DE (1) | DE69608891T2 (de) |
DK (1) | DK0823892T3 (de) |
ES (1) | ES2148772T3 (de) |
FI (1) | FI973530A (de) |
GB (1) | GB9509156D0 (de) |
GR (1) | GR3033715T3 (de) |
HK (1) | HK1014929A1 (de) |
HU (1) | HUP9801068A3 (de) |
IL (1) | IL118141A (de) |
MX (1) | MX9708510A (de) |
NO (1) | NO308948B1 (de) |
NZ (1) | NZ308471A (de) |
PE (1) | PE54797A1 (de) |
PL (1) | PL182857B1 (de) |
PT (1) | PT823892E (de) |
RU (1) | RU2169727C2 (de) |
SK (1) | SK282022B6 (de) |
TR (1) | TR199701298T1 (de) |
TW (1) | TW359667B (de) |
WO (1) | WO1996034849A1 (de) |
ZA (1) | ZA963540B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1458386B1 (de) * | 2001-12-27 | 2007-04-18 | Ortho-McNeil Pharmaceutical, Inc. | Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems |
AU2003241453A1 (en) | 2002-05-17 | 2003-12-02 | Janssen Pharmaceutica N.V. | Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
WO2005037286A1 (en) | 2003-03-25 | 2005-04-28 | Vasopharm Biotech Gmbh | Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia |
EP1956006A1 (de) | 2007-02-06 | 2008-08-13 | Laboratorios del Dr. Esteve S.A. | Heterocyclisch substituierte Tetrahydronaphthalenderivate als 5-HT7 Rezeptorliganden |
EP1975161A1 (de) * | 2007-03-28 | 2008-10-01 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituierte Tetrahydronaphthalenamin-Derivate, ihre Herstellung und Verwendung als Arzneimittel |
WO2008154044A1 (en) * | 2007-06-15 | 2008-12-18 | University Of Florida Research Foundation | Therapeutic compounds and methods of use |
EP2011786A1 (de) * | 2007-07-05 | 2009-01-07 | Laboratorios del Dr. Esteve S.A. | Indanamin-Derivate, ihre Herstellung und Verwendung als Arzneimittel |
CN106573872B (zh) * | 2014-05-19 | 2021-07-20 | 东北大学 | 5-羟色胺受体靶向化合物和方法 |
AU2021329920A1 (en) * | 2020-08-19 | 2023-04-27 | Northeastern University | Serotonin receptor modulators |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6045179B2 (ja) * | 1977-06-08 | 1985-10-08 | フナイ薬品工業株式会社 | 新規環状アミノアルコ−ル類およびその製造法 |
EP0257285A3 (de) | 1986-07-28 | 1989-12-27 | Whitby Research Incorporated | Verfahren und Zusammensetzungen zur Herabsetzung des Intraokular-Drucks von Säugetieren |
DE3718317A1 (de) | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
EP0381902A1 (de) | 1989-01-09 | 1990-08-16 | Merrell Dow Pharmaceuticals Inc. | Tetralin-Derivate |
JP2931986B2 (ja) | 1989-02-17 | 1999-08-09 | 武田薬品工業株式会社 | アラルキルアミン誘導体 |
SE8901889D0 (sv) | 1989-05-26 | 1989-05-26 | Astra Ab | Novel 8-substituted-2-aminotetralines |
ES2138639T3 (es) | 1993-08-27 | 2000-01-16 | Hoffmann La Roche | Derivados peptidicos de tetrahidronaftaleno. |
FR2711139B1 (fr) | 1993-10-15 | 1995-12-01 | Adir | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1995
- 1995-05-05 GB GBGB9509156.7A patent/GB9509156D0/en active Pending
-
1996
- 1996-05-02 CO CO96021819A patent/CO4440486A1/es unknown
- 1996-05-03 DK DK96919659T patent/DK0823892T3/da active
- 1996-05-03 AR ARP960102447A patent/AR004484A1/es unknown
- 1996-05-03 NZ NZ308471A patent/NZ308471A/xx unknown
- 1996-05-03 AU AU58129/96A patent/AU706392B2/en not_active Ceased
- 1996-05-03 SK SK1485-97A patent/SK282022B6/sk unknown
- 1996-05-03 IL IL11814196A patent/IL118141A/en not_active IP Right Cessation
- 1996-05-03 DE DE69608891T patent/DE69608891T2/de not_active Expired - Lifetime
- 1996-05-03 BR BR9608169A patent/BR9608169A/pt not_active IP Right Cessation
- 1996-05-03 RU RU97119872/04A patent/RU2169727C2/ru not_active IP Right Cessation
- 1996-05-03 AT AT96919659T patent/ATE193884T1/de not_active IP Right Cessation
- 1996-05-03 PL PL96323037A patent/PL182857B1/pl not_active IP Right Cessation
- 1996-05-03 ZA ZA9603540A patent/ZA963540B/xx unknown
- 1996-05-03 MX MX9708510A patent/MX9708510A/es not_active IP Right Cessation
- 1996-05-03 KR KR1019970707827A patent/KR100435009B1/ko not_active IP Right Cessation
- 1996-05-03 ES ES96919659T patent/ES2148772T3/es not_active Expired - Lifetime
- 1996-05-03 PE PE1996000309A patent/PE54797A1/es not_active Application Discontinuation
- 1996-05-03 EP EP96919659A patent/EP0823892B1/de not_active Expired - Lifetime
- 1996-05-03 TW TW085105300A patent/TW359667B/zh active
- 1996-05-03 CN CN96193739A patent/CN1122019C/zh not_active Expired - Fee Related
- 1996-05-03 WO PCT/EP1996/001841 patent/WO1996034849A1/en active IP Right Grant
- 1996-05-03 TR TR97/01298T patent/TR199701298T1/xx unknown
- 1996-05-03 PT PT96919659T patent/PT823892E/pt unknown
- 1996-05-03 CA CA002217855A patent/CA2217855C/en not_active Expired - Fee Related
- 1996-05-03 JP JP53301096A patent/JP3194965B2/ja not_active Expired - Fee Related
- 1996-05-03 CZ CZ19973486A patent/CZ292022B6/cs not_active IP Right Cessation
- 1996-05-03 HU HU9801068A patent/HUP9801068A3/hu unknown
-
1997
- 1997-08-27 FI FI973530A patent/FI973530A/fi not_active IP Right Cessation
- 1997-11-04 NO NO975087A patent/NO308948B1/no unknown
-
1998
- 1998-11-20 HK HK98112165A patent/HK1014929A1/xx not_active IP Right Cessation
-
1999
- 1999-06-28 US US09/340,818 patent/US6169116B1/en not_active Expired - Fee Related
-
2000
- 2000-06-16 GR GR20000401405T patent/GR3033715T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69422410T2 (de) | Polymerisationskataylsatoren, ihre herstellung und verwendung | |
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
DE68905205T2 (de) | Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin. | |
DE69405859D1 (de) | Fluorhaltige polymere, ihre herstellung und ihre verwendung | |
DE68907987T2 (de) | Filter und Dosierungsfläschchen sowie dessen Verwendung. | |
DE69814431D1 (de) | 3,3-diarylpropylamine , ihre verwendung und herstellung | |
ATE384528T1 (de) | Verwendung von einem faktor a inhibierenden oligosacchariden mit einem blutgerinnungshemmenden mittel zur behandlung von arterienthrombosen | |
DE69608891D1 (de) | Tetraline mit einem phenylsubstituenten am aromatischen ring und ihre verwendung in der behandlung von epilepsie, schlaganfall und gehirn- oder rückenmarkstrauma | |
DE59101729D1 (de) | Wasserunlösliche azofarbmittel, ihre herstellung und verwendung. | |
DE68910113T2 (de) | Wachstuminhibierendes mittel und dessen verwendung. | |
DE69207749D1 (de) | Kälteresistente pflanzen und ihre herstellung | |
ATE103918T1 (de) | 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung. | |
DE69534632T2 (de) | Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit | |
DE69428224T2 (de) | Schmalbandiges Filter mit variabler Zentralfrequenz | |
DE58908788D1 (de) | Modifizierte Blockpolymerisate, ihre Herstellung und Verwendung. | |
DE69114992T2 (de) | Kern-Schale-Polymer und dessen Anwendung. | |
DE69423705D1 (de) | Thermoplastische Fluorsilikonharze, ihre Herstellung und Verwendung | |
DE69223700T2 (de) | Zählerschaltung unter Verwendung eines Zählers vom Johnson-Typ und Anwendung derselben | |
NL192113B (nl) | Aromatische diaminoamide-monomeer, aromatisch polyamide en film daaruit, alsmede bereidings- en vervaardigingswerkwijzen. | |
DE68900867D1 (de) | 1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen. | |
DE69300037T2 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
ATE191219T1 (de) | Zwischenprodukte und ihre anwendung für die herstellung von n,n'-überbrückten bisindolylmaleimiden | |
DE69609879D1 (de) | Azofarbstoffe, ihre Herstellung und Verwendung | |
DE69007617T2 (de) | Sulfonierte aromatische kondensate und die behandlung von polyamidteppichen damit. | |
DE59308512D1 (de) | Cyclohexenonoximether, ihre herstellung und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |